New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 (‘Blue Mystic’)

2C-T-7 (‘Blue Mystic’), an illicit compound which shows similarities with MDMA and other designer drugs, has been only occasionally identified in the EU, but discussion on the Internet between experimenters has recently grown significantly. We aimed at collecting together in a review the available information on 2C-T-7, both at the cyber and at the street market level. 2C-T-7 was first synthesized in 1986; its desired effects include both a sense of empathy and of well-being. Hallucinations, nausea, anxiety, panic attacks and paranoid ideation are anecdotally reported. According to the different European sources here approached, the availability of 2C-T-7 at street level seems to be currently very low, although one death related to a mono-intoxication with 2C-T-7 has been documented in the USA. With respect to information on 2C-T-7 available online, due to both redundancy and relevance issues the initial identified sample of 360 was reduced to 118 websites. In 14 (11.9%) websites, the detailed description of the 2C-T-7 synthesis was given. Harm Reduction websites appeared significantly earlier in the search engines results’ list than Anti drugs (p 0.006) websites. Five (4.2%) websites apparently offered 2C-T-7 for sale. The large body of knowledge available online seems to contrast with small numbers of seizures at street level; an exhaustive web mapping of drug-related issues may be of interest for the clinician. Projects aimed at designing more ‘attractive’ prevention websites should be planned and future studies should better assess the characteristics of those consumers who take advantage of the online information of hallucinogenic compounds.

[1]  J. Halpern Hallucinogens: An update , 2003, Current psychiatry reports.

[2]  J. Sklerov,et al.  A general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC-EI-MS and HPLC-electrospray-MS. , 2004, Journal of analytical toxicology.

[3]  I. Bosman,et al.  A new trend in drugs-of-abuse; the 2C-series of phenethylamine designer drugs , 2004, Pharmacy World and Science.

[4]  Christopher R. Wolfe,et al.  Learning and Teaching on the World Wide Web , 2001 .

[5]  E. sanders-Bush,et al.  Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. , 1988, The Journal of pharmacology and experimental therapeutics.

[6]  G. Aghajanian,et al.  LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex. , 1996, The Journal of pharmacology and experimental therapeutics.

[7]  Fabrizio Schifano,et al.  Importance of Cyberspace for the Assessment of the Drug Abuse Market: Preliminary Results from the Psychonaut 2002 Project , 2003, Cyberpsychology, Behavior, and Social Networking.

[8]  P. Wax Just a click away: recreational drug Web sites on the Internet. , 2002, Pediatrics.

[9]  R. Glennon Do classical hallucinogens act as 5-HT2 agonists or antagonists? , 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[10]  A. Balestrieri,et al.  Acquired and crossed tolerance to mescaline, LSD-25, and BOL-148. , 1959, A.M.A. archives of general psychiatry.

[11]  J. Gewirtz,et al.  Behavioral Evidence for Interactions between a Hallucinogenic Drug and Group II Metabotropic Glutamate Receptors , 2000, Neuropsychopharmacology.

[12]  A. Shulgin,et al.  Structure-activity relationships of the classic hallucinogens and their analogs. , 1994, NIDA research monograph.

[13]  Robert G Carlson,et al.  Sources of information about MDMA (3,4-methylenedioxymethamphetamine): perceived accuracy, importance, and implications for prevention among young adult users. , 2004, Drug and alcohol dependence.

[14]  R. Glennon,et al.  Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens , 2004, Psychopharmacology.

[15]  Fabrizio Schifano,et al.  Internet pharmacies and online prescription drug sales: a cross-sectional study , 2005 .

[16]  P. Kemp,et al.  Postmortem identification and quantitation of 2,5-dimethoxy-4-n-propylthiophenethylamine using GC-MSD and GC-NPD. , 2003, Journal of analytical toxicology.

[17]  Giuseppe Riva,et al.  From real to Virtual Communities: Cognition, Knowledge, and Intention in the World Wide Web , 2001 .

[18]  F. Vollenweider Advances and Pathophysiological Models of Hallucinogenic Drug Actions in Humans: A Preamble to Schizophrenia Research , 1998, Pharmacopsychiatry.

[19]  G. Aghajanian,et al.  Serotonin and Hallucinogens , 1999, Neuropsychopharmacology.

[20]  E. sanders-Bush,et al.  Agonist-Directed Signaling of Serotonin 5-HT2C Receptors: Differences Between Serotonin and Lysergic Acid Diethylamide (LSD) , 1999, Neuropsychopharmacology.